December 26, 2025 11:14 AM
Solid Surge in Dr Reddys Laboratories Ltd Stock Price Today. Dr Reddys Laboratories Ltd Up by 0.34%
Dr Reddys Laboratories Ltd's stock has surged by 0.34%, and it is currently trading at 1270.10. Additionally, the stock maintains a PE ratio of 18.4200, while the industry PE is 33.3092.
December 26, 2025 10:16 AM
Live Market Data: Dr Reddys Laboratories Ltd Share Price Up 0.34% Today
The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.34% increase and currently trading at 1270.10 per share. Investors are taking notice of this upward momentum.
December 26, 2025 9:16 AM
Dr Reddys Laboratories Ltd on the Rise Today, up 0.13%
The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.13% increase. Presently, it is actively trading at 1267.50.
December 26, 2025 8:16 AM
Live Updates: Dr Reddys Laboratories Ltd Stock Loses Ground Today, Falls -0.19%
Dr Reddys Laboratories Ltd experienced a -0.19% dip in its share price and is currently trading at 1263.40. The stock has a PE ratio of 18.4200, an ROE of 16.0277 and a debt to equity ratio of 0.1625.
December 26, 2025 7:16 AM
Live Market Data: Dr Reddys Laboratories Ltd Share Price Surges Today
Dr Reddys Laboratories Ltd witnessed a notable 0.04% surge in its share price and is presently trading at 1266.30, captivating the attention of market participants.
December 26, 2025 6:16 AM
Solid Surge in Dr Reddys Laboratories Ltd Stock Price Today. Dr Reddys Laboratories Ltd Up by 0.36%
Dr Reddys Laboratories Ltd's stock has surged by 0.36%, and it is currently trading at 1270.40. Additionally, the stock maintains a PE ratio of 18.4200, while the industry PE is 33.3092.
December 26, 2025 5:15 AM
Live Market Data: Dr Reddys Laboratories Ltd Share Price Drops -0.09% Today
Dr Reddys Laboratories Ltd's share price has fallen by -0.09%, presenting both challenges and opportunities for investors. As of now, it's trading at 1264.60, and market participants are assessing the implications. The stock has a PE ratio of 18.4200, an ROE of 16.0277 and a debt to equity ratio of 0.1625.